Latest filing published 31 Aug 2018 for Creo Medical Group plc, €669k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Chris Hancock: trading record in brief
Chris Hancock is a declared insider of Creo Medical Group plc, with filings sourced from RNS (LSE). We count 2 filings; the first trade dates from 21 December 2017 and the latest from 30 August 2018.
The open-market side counts 1 purchase for €57k alongside 1 sale for €669k. The net balance comes to €612k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2018, the count stands at no purchases and 1 sale.
On 31 August 2018 came the latest disclosure, an open-market sale for €669k in Creo Medical Group plc. The most recent open-market purchase was published on 22 December 2017, 3,243 days ago. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Companies and markets linked to Chris Hancock
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 480,000 shares@ £1.25100.0% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:LSE20180831113008_13774848_20200330111400472_427-1
- 73,380 shares@ £0.695London Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:LSE20171222092429_13475778_20200330131510596_18780Canonical exit: 21 Mar 2018 (T+90)
2 of 2 declarations